Could the expectation that men need to be "manly" end up damaging their hearts? Researchers reveal a concerning trend among ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates ...

The Lagos State Government has launched a state-wide screening and public enlightenment campaign on hypertension and diabetes.

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

People with type 2 diabetes are at a high risk of developing severe health complications such as heart attacks, strokes, heart failure, and advanced kidney disease. However, recent research from ...

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with ...

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive ...

Sign up to our free email newsletter for daily roundups of the biggest headlines as well as all the latest breaking news ...

Share on PinterestMore evidence suggests that semaglutide drugs could help lower the risk of Alzheimer’s disease. Image ...

The boom experienced by the weight loss drug market comes as little surprise when considering that almost a third of the ...